The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...
An overview of the top 10 stories from Optometry Times in 2025.
The FDA approved Nufymco as an interchangeable biosimilar to Lucentis, making it the second approved ranibizumab biosimilar ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...
Money Talks News on MSN
Blind at 60. Vision restored at 61. Stanford research paves the way.
The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...
Approaching her 91st birthday, Dame Judi Dench has offered a poignant insight into her worsening eyesight, describing the decline as "crushing". The beloved actress, who was first diagnosed with ...
The CEO and founder of Science Corp discusses his company’s latest breakthrough: an ocular prosthesis, implanted with a chip under the retina ...
Something for the weekend - as 'rage bait' is declared word of year, how can we inoculate ourselves?
The Official Oxford Word of the Year 2025 is rage bait: Online content deliberately designed to elicit anger or outrage by being frustrating, provocative, or offensive, typically posted to increase ...
Abstract: Age-related macular degeneration (AMD) is a leading cause of vision loss in older people and is characterized by subtle retinal changes that make early identification difficult. Previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback